Silvercrest Asset Management’s Twist Bioscience TWST Stock Holding History

Silvercrest Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.2M	Sell	196,496 -47,529	-19%	-$3.09M	0.13%	204
2026 Q1	$11.6M	Sell	244,025 -25,068	-9%	-$1.12M	0.08%	287
2025 Q4	$8.54M	Buy	269,093 +767	+0.3%	+$23.9K	0.06%	346
2025 Q3	$7.55M	Sell	268,326 -6,409	-2%	-$194K	0.05%	362
2025 Q2	$10.1M	Buy	274,735 +78,166	+40%	+$2.7M	0.07%	310
2025 Q1	$7.72M	Buy	196,569 +24,226	+14%	+$1.09M	0.06%	339
2024 Q4	$8.01M	Sell	172,343 -1,627	-0.9%	-$73.5K	0.05%	341
2024 Q3	$7.86M	Buy	173,970 +35,727	+26%	+$1.7M	0.05%	302
2024 Q2	$6.81M	Buy	138,243 +4,028	+3%	+$164K	0.05%	345
2024 Q1	$4.6M	Buy	134,215 +37,376	+39%	+$1.35M	0.03%	404
2023 Q4	$3.57M	Hold	96,839	–	–	0.03%	424
2023 Q3	$1.96M	Sell	96,839 -49,057	-34%	-$1.08M	0.01%	488
2023 Q2	$2.99M	Buy	+145,896	New	+$2.19M	0.02%	437

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Silvercrest Asset Management's TWST Position: Q2 2026 in Review

Silvercrest Asset Management reduced its Twist Bioscience (TWST) stake by 19% in Q2 2026, selling an estimated $3.09M and leaving 196,496 shares worth $20.2M. The position accounts for 0.13% of the portfolio, ranked #204.

Silvercrest Asset Management first reported a position in TWST in Q2 2023 and has held it in 13 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Silvercrest Asset Management held 196,496 shares of Twist Bioscience worth $20.2M as of Q2 2026.
Silvercrest Asset Management sold 47,529 Twist Bioscience shares in Q2 2026, an estimated $3.09M.
Twist Bioscience made up 0.13% of Silvercrest Asset Management's portfolio in Q2 2026, its #204 holding.
Silvercrest Asset Management first reported a position in Twist Bioscience in Q2 2023 and has held it in 13 quarters since.
338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.